Erythropoietin (EPO) and MK-677 Interaction
Erythropoietin (EPO) and MK-677 have an interaction requiring monitoring for interaction with 51% confidence. Both Erythropoietin (EPO) and MK-677 can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). These compounds primarily affect different organ systems.
Compound Profiles
Erythropoietin (EPO)
EPO | Red Blood Cell Stimulating Hormone
EPO binds to erythropoietin receptors (EPOR) on erythroid progenitor cells in bone marrow, activating three interconnected signaling pathways: JAK2/STAT5, PI3K/AKT, and RAS/MAPK. This promotes survival of red blood cell precursors by protecting them from apoptosis, accelerates proliferation and differentiation of erythroid cells, and increases hemoglobin production.
View full profileMK-677
Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue
Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Erythropoietin (EPO) with MK-677?
Yes, but with caution. Both Erythropoietin (EPO) and MK-677 can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). Regular monitoring is advised.
Is Erythropoietin (EPO) and MK-677 safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: blood pressure raising, carcinogenic risk. Monitor accordingly.
What are the interactions between Erythropoietin (EPO) and MK-677?
Both Erythropoietin (EPO) and MK-677 can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time Erythropoietin (EPO) and MK-677?
Erythropoietin (EPO) has a half-life of 4-12 hours (IV), ~25 hours (SubQ) and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.